#$%^&*AU2019216631A120190905.pdf#####Abstract The present invention relates to the fields of life sciences and medicine. Specifically, the invention 5 relates to cancer therapies of humans. More specifically, the present invention relates to oncolytic adenoviral vectors alone or together with therapeutic compositions for therapeutic uses and therapeutic methods for cancer. In one aspect the present invention relates to separate 10 administration of adoptive cell therapeutic composition and oncolytic adenoviral vectors. Furthermore, the present invention relates to a pharmaceutical kit and a pharmaceutical composition, both utilizing oncolytic adenoviral vectors. C: NRPortbl GHMatters MICHELES 11579205_1.docx 1/08/19
